Skip to main content
logo
Outlook Therapeutics, Inc. (OTLK)
NASDAQ: OTLK · Real-Time Price · USD
0.4391
-0.0230 (-4.98%)
At close: Nov 5, 2026, 4:00 PM EST
0.4341
-0.0050 (-1.14%)
After-hours: Nov 5, 2026, 7:53 PM EST

Outlook Therapeutics Financials Overview

Millions USD. Fiscal year is Oct - Sep.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Revenue
-1.161.41----
Revenue Growth
------
Gross Profit
-2.280.06--26.45-42.33-38.96
Operating Income
-55.64-67.06-71.7-53.13-63.07-51.73
Net Income
-61.12-62.42-75.37-58.98-66.05-53.16
Earnings Per Share
-0.75-1.79-4.06-4.72-6.23-6.96
EPS Growth
------

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Cash & Investments
11.248.0814.9323.3917.414.48
Total Debt
18.4330.1929.7435.5610.9611.9
Net Cash (Debt)
-7.19-22.11-14.81-12.166.442.57
Net Cash Growth
----150.06%-66.60%
Net Cash Per Share
-0.09-0.64-0.80-0.970.610.34

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Operating Cash Flow
-56.15-51.83-68.79-42.97-56.67-54.25
Capital Expenditures
------
Free Cash Flow
-56.15-51.83-68.79-42.97-56.67-54.25
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Gross Margin
-4.05%----
Operating Margin
--4744.25%----
Pretax Margin
5387.10%-4526.01%----
Profit Margin
--4416.22%----
FCF Margin
--3666.65%----

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
PS Ratio
-33.31----